東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Biomarkers in carcinoma of unknown p...

Sarioglu, Sulen.

FindBook

Google Book

Amazon

博客來

Biomarkers in carcinoma of unknown primary

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Biomarkers in carcinoma of unknown primary/ edited by Sulen Sarioglu, Ozgul Sagol, Anil Aysal.
其他作者:	Sarioglu, Sulen.
出版者:	Cham :Springer International Publishing : : 2022.,
面頁冊數:	x, 473 p. :ill., digital ;24 cm.
內容註:	Chapter 1) Definition of "Tissue-based Biomarker", Its Place in Medicine and Molecular Pathology -- Chapter 2) The Concept and Mechanisms of Metastasis -- Chapter 3) Biomarkers in Skin Carcinomas -- Chapter 4) Biomarkers in Head and Neck Carcinomas -- Chapter 5) Biomarkers in Pulmonary Carcinomas -- Chapter 6) Biomarkers in Endocrine Organ Carcinomas -- Chapter 7) Biomarkers in Gastrointestinal System Carcinomas -- Chapter 8) Biomarkers in Hepatopancreatobiliary Carcinomas -- Chapter 9) Biomarkers in Urinary Tract and Male Genital System Carcinomas -- Chapter 10) Biomarkers in Gynecological Carcinomas -- Chapter 11) Biomarkers in Breast Carcinomas -- Chapter 12) Diagnostic Approach According to More Frequent Metastatic Sites-Liver, Lungs, Bone, Lymph Nodes -- Chapter 13) Diagnostic Approach According to Uncovered Metastatic Sites - Mediastinum-Timus, Peritoneum, Central Nervous System, Soft Tissue -- Chapter 14) Management of the Patients with Primary Unknown Carcinoma and the Role of Biomarkers -- Chapter 15) Treatment Approach to Carcinomas of Unknown Primary -- Appendix.
Contained By:	Springer Nature eBook
標題:	Cancer - Molecular aspects. -
電子資源:	https://doi.org/10.1007/978-3-030-84432-5
ISBN:	9783030844325

Biomarkers in carcinoma of unknown primary
Biomarkers in carcinoma of unknown primary[electronic resource] /edited by Sulen Sarioglu, Ozgul Sagol, Anil Aysal. - Cham :Springer International Publishing :2022. - x, 473 p. :ill., digital ;24 cm.

Chapter 1) Definition of "Tissue-based Biomarker", Its Place in Medicine and Molecular Pathology -- Chapter 2) The Concept and Mechanisms of Metastasis -- Chapter 3) Biomarkers in Skin Carcinomas -- Chapter 4) Biomarkers in Head and Neck Carcinomas -- Chapter 5) Biomarkers in Pulmonary Carcinomas -- Chapter 6) Biomarkers in Endocrine Organ Carcinomas -- Chapter 7) Biomarkers in Gastrointestinal System Carcinomas -- Chapter 8) Biomarkers in Hepatopancreatobiliary Carcinomas -- Chapter 9) Biomarkers in Urinary Tract and Male Genital System Carcinomas -- Chapter 10) Biomarkers in Gynecological Carcinomas -- Chapter 11) Biomarkers in Breast Carcinomas -- Chapter 12) Diagnostic Approach According to More Frequent Metastatic Sites-Liver, Lungs, Bone, Lymph Nodes -- Chapter 13) Diagnostic Approach According to Uncovered Metastatic Sites - Mediastinum-Timus, Peritoneum, Central Nervous System, Soft Tissue -- Chapter 14) Management of the Patients with Primary Unknown Carcinoma and the Role of Biomarkers -- Chapter 15) Treatment Approach to Carcinomas of Unknown Primary -- Appendix.

This book aims to examine all immunohistochemical and molecular pathological biomarkers that can be useful and effective in patient diagnosis, prognosis and treatment decision, especially when faced with a carcinoma of unknown primary. For this purpose, epithelial malignancies of all systems and related biomarkers are examined one by one, and to look at the subject through the metastatic regions window, biomarkers that can be used to determine the primary focus for carcinomas seen in the areas most frequently metastasized are emphasized. With this bi-directional perspective, the reader is able to find biomarkers of any type of carcinoma on a system basis, as well as access to which biomarkers can be used when faced with a metastatic carcinoma. The importance of biomarkers in patient follow-up and treatment is also conveyed through the clinician's eye, and so biomarkers are handled with a holistic approach in all aspects. This book primarily targets pathologists, as well as clinicians (oncologists and surgeons) who manage cancer patients.

ISBN: 9783030844325

Standard No.: 10.1007/978-3-030-84432-5doiSubjects--Topical Terms:

661419
Cancer
--Molecular aspects.

LC Class. No.: RC268.5 / .B56 2022

Dewey Class. No.: 616.9940421

Biomarkers in carcinoma of unknown primary
LDR:03131nmm a2200325 a 4500 001 2297592
003 DE-He213
005 20211216160409.0
006 m d
007 cr nn 008maaau
008 230324s2022 sz s 0 eng d
020 $a 9783030844325 $q (electronic bk.)
020 $a 9783030844318 $q (paper)
024 7 $a 10.1007/978-3-030-84432-5 $2 doi
035 $a 978-3-030-84432-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RC268.5 $b .B56 2022
072 7 $a MMF $2 bicssc
072 7 $a MED067000 $2 bisacsh
072 7 $a MKF $2 thema
082 0 4 $a 616.9940421 $2 23
090 $a RC268.5 $b .B615 2022
245 0 0 $a Biomarkers in carcinoma of unknown primary $h [electronic resource] / $c edited by Sulen Sarioglu, Ozgul Sagol, Anil Aysal.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2022.
300 $a x, 473 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1) Definition of "Tissue-based Biomarker", Its Place in Medicine and Molecular Pathology -- Chapter 2) The Concept and Mechanisms of Metastasis -- Chapter 3) Biomarkers in Skin Carcinomas -- Chapter 4) Biomarkers in Head and Neck Carcinomas -- Chapter 5) Biomarkers in Pulmonary Carcinomas -- Chapter 6) Biomarkers in Endocrine Organ Carcinomas -- Chapter 7) Biomarkers in Gastrointestinal System Carcinomas -- Chapter 8) Biomarkers in Hepatopancreatobiliary Carcinomas -- Chapter 9) Biomarkers in Urinary Tract and Male Genital System Carcinomas -- Chapter 10) Biomarkers in Gynecological Carcinomas -- Chapter 11) Biomarkers in Breast Carcinomas -- Chapter 12) Diagnostic Approach According to More Frequent Metastatic Sites-Liver, Lungs, Bone, Lymph Nodes -- Chapter 13) Diagnostic Approach According to Uncovered Metastatic Sites - Mediastinum-Timus, Peritoneum, Central Nervous System, Soft Tissue -- Chapter 14) Management of the Patients with Primary Unknown Carcinoma and the Role of Biomarkers -- Chapter 15) Treatment Approach to Carcinomas of Unknown Primary -- Appendix.
520 $a This book aims to examine all immunohistochemical and molecular pathological biomarkers that can be useful and effective in patient diagnosis, prognosis and treatment decision, especially when faced with a carcinoma of unknown primary. For this purpose, epithelial malignancies of all systems and related biomarkers are examined one by one, and to look at the subject through the metastatic regions window, biomarkers that can be used to determine the primary focus for carcinomas seen in the areas most frequently metastasized are emphasized. With this bi-directional perspective, the reader is able to find biomarkers of any type of carcinoma on a system basis, as well as access to which biomarkers can be used when faced with a metastatic carcinoma. The importance of biomarkers in patient follow-up and treatment is also conveyed through the clinician's eye, and so biomarkers are handled with a holistic approach in all aspects. This book primarily targets pathologists, as well as clinicians (oncologists and surgeons) who manage cancer patients.
650 0 $a Cancer $x Molecular aspects. $3 661419
650 0 $a Biochemical markers. $3 587592
650 1 4 $a Pathology. $3 643180
650 2 4 $a Oncology. $3 751006
650 2 4 $a Surgery. $3 707153
650 2 4 $a Gastroenterology. $3 828956
650 2 4 $a Medical and Radiation Physics. $3 1532864
700 1 $a Sarioglu, Sulen. $3 3301131
700 1 $a Sagol, Ozgul. $3 3593392
700 1 $a Aysal, Anil. $3 3593393
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-030-84432-5
950 $a Medicine (SpringerNature-11650)